These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 9712335)
1. Changes in the aortic endothelium and plasma von Willebrand factor levels during the onset and progression of insulin-dependent diabetes in BB rats. Ribau JC; Hatton MW; Richardson M Atherosclerosis; 1998 Aug; 139(2):291-9. PubMed ID: 9712335 [TBL] [Abstract][Full Text] [Related]
2. Aortic endothelial cell von Willebrand factor content, and circulating plasminogen activator inhibitor-1 are increased, but expression of endothelial leukocyte adhesion molecules is unchanged in insulin-dependent diabetic BB rats. Ribau JC; Samis JA; Senis YA; Maurice DH; Giles AR; DeReske M; Absher PM; Hatton MW; Richardson M Atherosclerosis; 2000 Apr; 149(2):331-42. PubMed ID: 10729383 [TBL] [Abstract][Full Text] [Related]
3. Intimal deposition of functional von Willebrand factor in atherogenesis. De Meyer GR; Hoylaerts MF; Kockx MM; Yamamoto H; Herman AG; Bult H Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2524-34. PubMed ID: 10521383 [TBL] [Abstract][Full Text] [Related]
4. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII). Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174 [TBL] [Abstract][Full Text] [Related]
5. Morphological alterations in endothelial cells associated with the release of von Willebrand factor after thrombin generation in vivo. Richardson M; Tinlin S; De Reske M; Webster S; Senis Y; Giles AR Arterioscler Thromb; 1994 Jun; 14(6):990-9. PubMed ID: 8199191 [TBL] [Abstract][Full Text] [Related]
6. Injury induces increase of von Willebrand factor in rat endothelial cells. Reidy MA; Chopek M; Chao S; McDonald T; Schwartz SM Am J Pathol; 1989 Apr; 134(4):857-64. PubMed ID: 2650559 [TBL] [Abstract][Full Text] [Related]
7. Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy. Fujiwara Y; Tagami S; Kawakami Y J Atheroscler Thromb; 1998; 5(1):21-8. PubMed ID: 10077454 [TBL] [Abstract][Full Text] [Related]
9. Differential intracellular trafficking of von Willebrand factor (vWF) and vWF propeptide in porcine endothelial cells lacking Weibel-Palade bodies and in human endothelial cells. Royo T; Martínez-González J; Vilahur G; Badimon L Atherosclerosis; 2003 Mar; 167(1):55-63. PubMed ID: 12618268 [TBL] [Abstract][Full Text] [Related]
10. Changes in the pattern of distribution of von Willebrand factor in rat aortic endothelial cells following thrombin generation in vivo. Senis YA; Richardson M; Tinlin S; Maurice DH; Giles AR Br J Haematol; 1996 Apr; 93(1):195-203. PubMed ID: 8611460 [TBL] [Abstract][Full Text] [Related]
11. von Willebrand factor and its propeptide in children with diabetes. Relation between endothelial dysfunction and microalbuminuria. Verrotti A; Greco R; Basciani F; Morgese G; Chiarelli F Pediatr Res; 2003 Mar; 53(3):382-6. PubMed ID: 12595584 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: preliminary studies. Qin F; Impeduglia T; Schaffer P; Dardik H J Vasc Surg; 2003 Feb; 37(2):433-9. PubMed ID: 12563218 [TBL] [Abstract][Full Text] [Related]
13. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification. Chan NN; Fuller JH; Rubens M; Colhoun HM Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448 [TBL] [Abstract][Full Text] [Related]
14. Von Willebrand factor targets IL-8 to Weibel-Palade bodies in an endothelial cell line. Romani de Wit T; de Leeuw HP; Rondaij MG; de Laaf RT; Sellink E; Brinkman HJ; Voorberg J; van Mourik JA Exp Cell Res; 2003 May; 286(1):67-74. PubMed ID: 12729795 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. Pinsky DJ; Naka Y; Liao H; Oz MC; Wagner DD; Mayadas TN; Johnson RC; Hynes RO; Heath M; Lawson CA; Stern DM J Clin Invest; 1996 Jan; 97(2):493-500. PubMed ID: 8567972 [TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation. van Mourik JA; Boertjes R; Huisveld IA; Fijnvandraat K; Pajkrt D; van Genderen PJ; Fijnheer R Blood; 1999 Jul; 94(1):179-85. PubMed ID: 10381511 [TBL] [Abstract][Full Text] [Related]
17. The effect of near-normoglycemic control on plasma factor VIII/von Willebrand factor and fibrin degradation products in insulin-dependent diabetic patients. Vukovich TC; Schernthaner G; Knöbi PN; Hay U J Clin Endocrinol Metab; 1989 Jul; 69(1):84-9. PubMed ID: 2659619 [TBL] [Abstract][Full Text] [Related]
18. Human C-reactive protein induces endothelial dysfunction in biobreeding diabetic rats. Jialal I; Kaur H; Devaraj S; Smith G Diab Vasc Dis Res; 2013 Nov; 10(6):550-3. PubMed ID: 24028935 [TBL] [Abstract][Full Text] [Related]
19. Measurement of von Willebrand factor-specific mRNA and release and storage of von Willebrand factor from endothelial cells of dogs with type-I von Willebrand's disease. Meinkoth JH; Meyers KM Am J Vet Res; 1995 Dec; 56(12):1577-85. PubMed ID: 8599517 [TBL] [Abstract][Full Text] [Related]
20. Continued platelet interaction with de-endothelialized aortae associated with slower re-endothelialization and more extensive intimal hyperplasia in spontaneously diabetic BB Wistar rats. Winocour PD; Richardson M; Kinlough-Rathbone RL Int J Exp Pathol; 1993 Dec; 74(6):603-13. PubMed ID: 8292558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]